Significant Association Between Huntingtin Gene Mutation and Prevalence of Hopelessness, Depression and Anxiety Symptoms
Open Access
- 18 January 2021
- journal article
- review article
- Published by Vilnius University Press in Acta medica Lituanica
- Vol. 28 (1), 77-85
- https://doi.org/10.15388/amed.2020.28.1.4
Abstract
Background: In Huntington’s disease psychiatric symptoms may manifest prior to motor dysfunction. Such symptoms negatively impact people’s quality of life and can worsen the course of the primary disease. The aim of the present study was to assess and compare depression, anxiety and hopelessness rates in individuals with and without an abnormal expansion of CAG repeats in the huntingtin (HTT) gene and healthy controls.Materials and methods: Study involved 31 individuals referred for genetic testing for Huntington’s disease and a control group of 41. Depressive and anxiety symptoms were assessed using Beck Hopelessness Scale (BHS) and Hospital Anxiety and Depression Scale (HADS). Results between groups were compared using the Mann–Whitney U test. Two-sided Bonferroni corrected p-value was set at ≤0.017.Results: Individuals with HTT gene mutation (“gene mutation positive”, GMP) (N=20) scored higher on the HADS depression subscale (5.90 ± 4.52 vs 1.36 ± 1.91; p ≤ 0.017) than those without HTT gene mutation (“gene mutation negative”, GMN) (N=11). GMP and control groups scored higher than the GMN group on the BHS (5.65 ± 3.91 vs 2.09 ± 1.64 and 5.27 ± 4.11 vs 2.09 ± 1.64, respectively; p ≤ 0.017). No differences in anxiety levels were found.Conclusions: Depressive symptoms and hopelessness were more prevalent in individuals with HTT gene mutation than in individuals who were tested but had no said mutation. Such results emphasise the importance of timely diagnosis and treatment of psychiatric comorbidities in individuals affected by Huntington’s disease.Keywords
This publication has 41 references indexed in Scilit:
- Depression in the early stages of Huntington diseaseNeurodegenerative Disease Management, 2011
- Suicidal Behavior in Prodromal Huntington DiseaseNeurodegenerative Diseases, 2011
- Depression in patients with Huntington disease correlates with alterations of the brain stem raphe depicted by transcranial sonographyJournal of Psychiatry and Neuroscience, 2011
- Up-regulation of the isoenzymes MAO-A and MAO-B in the human basal ganglia and pons in Huntington's disease revealed by quantitative enzyme radioautographyBrain Research, 2011
- A retrospective study of the impact of lifestyle on age at onset of Huntington diseaseMovement Disorders, 2010
- Chronic low dose corticosterone exposure decreased hippocampal cell proliferation, volume and induced anxiety and depression like behaviours in miceEuropean Journal of Pharmacology, 2008
- Depressive disorders—is it time to endorse different pathophysiologies?Psychoneuroendocrinology, 2006
- Critical Periods of Suicide Risk in Huntington’s DiseaseAmerican Journal of Psychiatry, 2005
- Caspases in Huntington’s DiseaseThe Neuroscientist, 2001
- The measurement of pessimism: The Hopelessness Scale.Journal of Consulting and Clinical Psychology, 1974